1AI Insider Trading

Insider Ownership Percentage: 40.59%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Algorae Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Algorae Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Algorae Pharmaceuticals Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 10/18/2023 12:02 PM ET

This chart shows the closing price history over time for 1AI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Algorae Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/22/2024Bradley DilkesInsiderCancelled20,000,000A$0.01A$240,000.00
12/28/2023David HainsworthInsiderExercise10,000,000A$0.01A$110,000.00
11/9/2023Bradley LathamInsiderIssued20,000,000A$0.01A$260,000.00
10/10/2023David HainsworthInsiderIssued40,000,000A$0.01A$560,000.00
See Full Table

SEC Filings (Institutional Ownership Changes) for Algorae Pharmaceuticals (ASX:1AI)

Algorae Pharmaceuticals Limited, a biotechnology company, focuses on developing solutions for Parkinson's disease in Australia. It is developing NTCELL, an alginate coated capsule to target the treatment of Parkinson's disease; and AI-116, a novel combination drug candidate, which includes cannabidiol and an off-patent pharmaceutical ingredient treatment for dementia, including Alzheimer's disease. The company was formerly known as Living Cell Technologies Limited and changed its name to Algorae Pharmaceuticals Limited in September 2023. The company was founded in 1987 and is based in Melbourne, Australia.
Read More on Algorae Pharmaceuticals

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A



Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Algorae Pharmaceuticals?

Algorae Pharmaceuticals' top insider shareholders include:
  1. Bradley Dilkes (Insider)
  2. Bradley Latham (Insider)
  3. David Hainsworth (Insider)
Learn More about top insider investors at Algorae Pharmaceuticals.